Overview
Status
Active
Registry date
2017-03-21
Limited partner contribution
60,000.00 PLN
Registered address
ul. Świętopełka 39, 81-524 Gdynia, Poland
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 3 of 6 financial statements were filed late (the longest delay 402 days for 2020).
- 2025not filed
- 202424/06/2025
- 202314/06/2024
- 202214/06/2024
- 202115/07/2023
- 202021/11/2022
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Partners
| Partners |
|---|
Rafał Maciej Barskiage 49 |
Manner of representation
The company is represented by the general partner.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Was a VAT taxpayer from 2017-07-06 to 2023-03-23.
Reason for removal: Art. 96 ust. 9a pkt 3 (VAT returns showing no transactions filed for 6 consecutive months or 2 quarters)
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Zakłady Farmaceutyczne PolpharmaS.A. | $780,704,907.94 | polpharma.pl | ||
| Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - LekS.A. | $119,621,017.71 | hasco-lek.pl | ||
| BiotonS.A. | $72,911,351.08 | bioton.com | ||
| Curtis Health CapsS.A. | $30,831,117.38 | chc.com.pl | ||
| Labofarmsp. z o.o. | $6,814,569.78 | labofarm.pl | ||
| PoltregS.A. | $1,906,011.66 | poltreg.com | ||
| Labor Przedsiębiorstwo Farmaceutyczno - Chemicznesp. z o.o. | $1,184,204.34 | labor.com.pl | ||
| Biomarsp. z o.o. | $909,113.28 | biomar.pl | ||
| Human BiomeS.A. | $888,361.19 | human-biome.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-07-13 | Business resumed | |
| 2024-07-12 | Business suspended | |
| 2017-03-21 | Entered in the register |
FAQ
The main business activity of Nutree Lab Barski focuses on manufacture of pharmaceutical preparations.
The company was registered in the Polish National Court Register (KRS) on March 21, 2017.
The headquarters is located at: ul. Świętopełka 39, 81-524 Gdynia.
The share capital of the company is PLN 60,000 (approx. $16,207).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
No, the company recorded a net loss of $1,285 in 2024. For comparison, in 2023 the loss was $1,214, meaning the company increased its loss by 0.6%.
The largest operating cost category falls under employee remuneration. This category amounted to $1,285 in 2024, representing 100% of all operating expenses.
Last updated: 2026-07-16